tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Theriva Biologics Presents Promising Phase 2b Trial Data
PremiumCompany AnnouncementsTheriva Biologics Presents Promising Phase 2b Trial Data
29d ago
Theriva Biologics Presents Promising VCN-12 Preclinical Data
Premium
Company Announcements
Theriva Biologics Presents Promising VCN-12 Preclinical Data
1M ago
Theriva Biologics Unveils VCN-12 Preclinical Data
Premium
Company Announcements
Theriva Biologics Unveils VCN-12 Preclinical Data
1M ago
Theriva Biologics reports Q2 EPS ($1.93) vs. ($10.72) last year
PremiumThe FlyTheriva Biologics reports Q2 EPS ($1.93) vs. ($10.72) last year
3M ago
Theriva Biologics sees cash runway into 1Q26
Premium
The Fly
Theriva Biologics sees cash runway into 1Q26
3M ago
Theriva Biologics Sets 2025 Shareholder Meeting Date
Premium
Company Announcements
Theriva Biologics Sets 2025 Shareholder Meeting Date
5M ago
Theriva Biologics sees cash runway into 1Q26
PremiumThe FlyTheriva Biologics sees cash runway into 1Q26
6M ago
Theriva Biologics Completes $7.5 Million Public Offering
Premium
Company Announcements
Theriva Biologics Completes $7.5 Million Public Offering
6M ago
Theriva Biologics downgraded to Hold from Buy at Maxim
Premium
The Fly
Theriva Biologics downgraded to Hold from Buy at Maxim
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100